CME/CE
Translating Evidence into IgAN Care
8:45
Faculty: Jonathan Barratt, MD, PhD Faculty: Jörg Latus, MD
This comprehensive educational activity focuses on 4 key dimensions of IgA nephropathy (IgAN) management. First, attendees will compare and contrast the mechanisms of action (MOAs) of both approved and investigational IgAN therapies, critically evaluating how each targets specific disease pathways—such as galactose-deficient IgA1…